Skip to main content
Clinical Trials/NCT03128242
NCT03128242
Unknown
Not Applicable

An Eye-tracking Study to Investigate Oxytocin's Effect on Attentional Bias Training

University of Electronic Science and Technology of China1 site in 1 country60 target enrollmentNovember 25, 2016
ConditionsHealthy
InterventionsOxytocinplacebo

Overview

Phase
Not Applicable
Intervention
Oxytocin
Conditions
Healthy
Sponsor
University of Electronic Science and Technology of China
Enrollment
60
Locations
1
Primary Endpoint
Reaction time (RT) difference - oxytocin effects
Last Updated
7 years ago

Overview

Brief Summary

This study aims to investigate oxytocin's effect on attentional bias training. Healthy participants will undergo a dot-probe task-based training to direct their attention away from negative stimuli (as compared to neutral). Effects of the training will be assessed using an eye-tracking anti-saccade task.

Detailed Description

In this study, a dot-probe task will be used to examine if subjects show an attentional bias towards negative stimuli and whether the bias can be modified using a subsequent attentional bias training. During this training participants learn to direct their attention away from threatening stimuli. In a between-subject placebo controlled design participants will receive either intranasal oxytocin or placebo before the training to examine whether oxytocin could facilitate the effects of the attention training. Effects of the training and of oxytocin on the training will be assessed by means of an eye-tracking anti-saccade task. Based on previous studies showing the strongest effects of threat-attentional bias training in high anxious subjects, the study will recruit participants with an elevated trait anxiety.

Registry
clinicaltrials.gov
Start Date
November 25, 2016
End Date
December 30, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Sponsor
University of Electronic Science and Technology of China
Responsible Party
Principal Investigator
Principal Investigator

Benjamin Becker

Professor

University of Electronic Science and Technology of China

Eligibility Criteria

Inclusion Criteria

  • male participants with elevated trait anxiety (\> 45 scores as assessed with the State and Trait Anxiety Inventory, Spielberger, 1983)
  • without past or current psychiatric or neurological disorders

Exclusion Criteria

  • history of head injury
  • medical or psychiatric illness
  • smoking or drinking 24 hours before the experiment

Arms & Interventions

oxytocin group

oxytocin treatment

Intervention: Oxytocin

placebo group

placebo treatment

Intervention: placebo

Outcomes

Primary Outcomes

Reaction time (RT) difference - oxytocin effects

Time Frame: Before drug administration (pre-treatment baseline) and 55 minutes after drug administration

Difference before and after oxytocin administration: reaction time to negative and neutral stimuli in the dot-probe task

Reaction time (RT) difference - training effects

Time Frame: Before drug administration - 55-90 minutes after drug administration

Difference before and after training: reaction time to negative and neutral stimuli in the dot-probe task

Saccade latency difference - training effects

Time Frame: Before drug administration - 55-90 minutes after drug administration

Difference before and after training in saccade latency in the anti-saccade task

Study Sites (1)

Loading locations...

Similar Trials